The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival outcomes of the NeoALTTO study: Updated results of a randomized multicenter phase III neoadjuvant trial.
 
Jens Bodo Huober
Honoraria - Novartis; Roche
Consulting or Advisory Role - Novartis; Roche
Travel, Accommodations, Expenses - Novartis; Roche
 
Eileen McCormick Holmes
No Relationships to Disclose
 
Jose Baselga
Leadership - Infinity Pharmaceuticals; Varian Medical Systems
Stock and Other Ownership Interests - GRAIL; Infinity Pharmaceuticals; Juno Therapeutics; PMV Pharma; Varian Medical Systems
Consulting or Advisory Role - Eli Lilly, Novartis; GRAIL
 
Evandro De Azambuja
Honoraria - Roche/Genentech
Consulting or Advisory Role - Roche/Genentech
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Roche/Genentech
 
Michael Untch
No Relationships to Disclose
 
Debora Fumagalli
No Relationships to Disclose
 
Severine Sarp
Employment - Novartis
 
Istvan Lang
No Relationships to Disclose
 
Ian E. Smith
No Relationships to Disclose
 
Frances M. Boyle
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Novartis
Other Relationship - Paxman
 
Binghe Xu
No Relationships to Disclose
 
Christophe Lecocq
No Relationships to Disclose
 
Lorena De La Pena
No Relationships to Disclose
 
Christian Jackisch
Honoraria - Roche
Travel, Accommodations, Expenses - Roche
 
Richard D. Gelber
Research Funding - AstraZeneca (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Martine J. Piccart-Gebhart
Consulting or Advisory Role - AstraZeneca; Crescendo Biologics; Debiopharm Group; HUYA Bioscience International; Lilly; MSD; Novartis; Periphagen; Pfizer; PharmaMar; Radius Health; Roche/Genentech
Research Funding - AstraZeneca (Inst); Crescendo Bioscience (Inst); Debiopharm Group (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Periphagen (Inst); Pfizer (Inst); PharmaMar (Inst); Radius Health (Inst); Roche/Genentech (Inst)
 
Serena Di Cosimo
No Relationships to Disclose